Skip to main content

Table 1 Clinical information for binding assay studies

From: Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue

  Age (Years) Gender (M/F) ApoE (E/E) Braak stage Postmortem delay (hours)
Alzheimer cases 59 F 4/4 5 4
61 M 3/3 5 4
66 F 4/3 5 7
70 M 4/4 4 4
75 F 4/4 5 6
78 M 4/4 5 7
81 F 4/3 5 6
85 F 3/3 4 6
72 ± 9 3 M/5 F 2 E3 4-5 5 ± 1
6 E4
Controls 50 F 3/3 1 17
62 M 3/3 1 7
71 F 3/2 1 7
77 F 3/3 1 3
78 M 3/3 1 7
79 M 3/3 2 9
81 M 3/3 2 8
84 F 3/3 1 4
73 ± 11 4 M/4 F 8 E3 1-2 8 ± 4
0 E4
  1. The table presents information for the binding studies cases from which homogenates have been extracted. The age at death, gender, apolipoprotein E (ApoE) genotype, Braak stage at cerebral pathological assessment, and post-mortem delay are given for each patient included in the study
  2. M = male; F = Female. Temporal lobes from AD cases mentioned in bold have been used for the saturation and competition studies, as well as the hippocampus from the 75 years-old AD case